U-Chart Analysis:Takeda Pharmaceutical Company Limited:4502

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Takeda Pharmaceutical Company Limited Go to web site 4502 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Takeda Pharmaceutical Company Limited Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Takeda Pharmaceutical Company Limited Balance Sheet 2023年3月期 Takeda Pharmaceutical Company Limited Balance Sheet 2022年3月期 Takeda Pharmaceutical Company Limited Balance Sheet 2021年3月期 Takeda Pharmaceutical Company Limited Balance Sheet 2020年3月期 Takeda Pharmaceutical Company Limited Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 533,530 849,695 966,222 637,614 702,093
Other Current AssetsHelp 1,864,426 1,743,947 1,746,671 1,831,818 2,290,944
Tangible Fixed AssetsHelp 1,691,229 1,582,800 1,453,917 1,386,370 1,331,931
Intangible Fixed AssetHelp 4,269,657 3,818,544 3,909,106 4,171,361 4,751,169
Investments and OthersHelp 808,185 775,283 802,460 781,403 476,385
Total AssetsHelp 13,957,750 13,178,018 12,912,293 12,821,094 13,792,773
Total Current LiabilitiesHelp 3,560,886 3,353,581 3,126,038 3,591,124 3,844,783
Total Long-term LiabilitiesHelp 4,042,741 4,141,418 4,613,218 4,506,487 4,766,005
Shareholder's EquityHelp 6,354,123 5,683,019 5,173,037 4,723,483 5,181,985
Total LiabilitiesHelp 13,957,750 13,178,018 12,912,293 12,821,094 13,792,773

Takeda Pharmaceutical Company Limited Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Takeda Pharmaceutical Company Limited Profit and Loss Account 2023年3月期 Takeda Pharmaceutical Company Limited Profit and Loss Account 2022年3月期 Takeda Pharmaceutical Company Limited Profit and Loss Account 2021年3月期 Takeda Pharmaceutical Company Limited Profit and Loss Account 2020年3月期 Takeda Pharmaceutical Company Limited Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 4,027,478 3,569,006 3,197,812 3,291,188 2,097,224
Total Sales 4,027,478 3,569,006 3,197,812 3,291,188 2,097,224
Cost of SalesHelp 1,244,072 1,106,846 994,308 1,089,764 651,729
Other Costs and RevenueHelp 2,466,389 2,232,101 1,827,499 2,157,183 1,310,303
Total CostsHelp 3,710,461 3,338,947 2,821,807 3,246,947 1,962,032
Net RevenueHelp 2,783,406 2,462,160 2,203,504 2,201,424 1,445,495
Earnings Before TaxHelp 375,090 302,571 366,235 -60,754 127,612
Net IncomeHelp 317,017 230,059 376,005 44,241 135,192
Net Income 317,017 230,059 376,005 44,241 135,192

Takeda Pharmaceutical Company Limited Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Takeda Pharmaceutical Company Limited Cash Flow Statement 2023年3月期 Takeda Pharmaceutical Company Limited Cash Flow Statement 2022年3月期 Takeda Pharmaceutical Company Limited Cash Flow Statement 2021年3月期 Takeda Pharmaceutical Company Limited Cash Flow Statement 2020年3月期 Takeda Pharmaceutical Company Limited Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help 977,156 1,123,105 1,010,931 670,381 328,301
Investing Cash Flow(ICF)Help -607,102 -198,125 393,530 292,119 -2,835,698
Financing Cash FlowHelp -709,148 -1,070,265 -1,088,354 -1,005,213 2,946,237
Exchange Difference of Cash and Cash EquivalentsHelp 22,929 28,758 12,501 -21,766 -31,269
Net Increase and Decrease in Cash and Cash Equivalentsn -316,165 -116,527 328,608 -64,479 407,571

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Takeda Pharmaceutical Company Limited

Company where related level is highHelp

RIBOMIC Inc.
SSP CO.,LTD.
Solasia Pharma K.K.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Shionogi & Co.,Ltd.
Perseus Proteomics Inc.
Nichi-Iko Pharmaceutical Co.,Ltd.
STELLA PHARMA CORPORATION
Kubota Pharmaceutical Holdings Co.,Ltd.
Sumitomo Pharma Co., Ltd.